These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 11866001)

  • 21. Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: Results from a 6-week, randomized, placebo-controlled, clinical trial.
    Hanania NA; Boota A; Kerwin E; Tomlinson L; Denis-Mize K
    Drugs; 2009 Jun; 69(9):1205-16. PubMed ID: 19537837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tiotropium and exercise training in COPD patients: effects on dyspnea and exercise tolerance.
    Ambrosino N; Foglio K; Balzano G; Paggiaro PL; Lessi P; Kesten S;
    Int J Chron Obstruct Pulmon Dis; 2008; 3(4):771-80. PubMed ID: 19281092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A blinded evaluation of the efficacy and safety of glycopyrronium, a once-daily long-acting muscarinic antagonist, versus tiotropium, in patients with COPD: the GLOW5 study.
    Chapman KR; Beeh KM; Beier J; Bateman ED; D'Urzo A; Nutbrown R; Henley M; Chen H; Overend T; D'Andrea P
    BMC Pulm Med; 2014 Jan; 14():4. PubMed ID: 24438744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of tiotropium Respimat SMI in COPD in two 1-year randomized studies.
    Bateman E; Singh D; Smith D; Disse B; Towse L; Massey D; Blatchford J; Pavia D; Hodder R
    Int J Chron Obstruct Pulmon Dis; 2010 Aug; 5():197-208. PubMed ID: 20714373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tiotropium reduces risk of exacerbations irrespective of previous use of inhaled anticholinergics in placebo-controlled clinical trials.
    Cooper CB; Anzueto A; Decramer M; Celli B; Tashkin DP; Leimer I; Kesten S
    Int J Chron Obstruct Pulmon Dis; 2011; 6():269-75. PubMed ID: 21845038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tiotropium bromide inhalation powder: a review of its use in the management of chronic obstructive pulmonary disease.
    Keating GM
    Drugs; 2012 Jan; 72(2):273-300. PubMed ID: 22217233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide.
    Wedzicha JA; Calverley PM; Seemungal TA; Hagan G; Ansari Z; Stockley RA;
    Am J Respir Crit Care Med; 2008 Jan; 177(1):19-26. PubMed ID: 17916806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol.
    Donohue JF; van Noord JA; Bateman ED; Langley SJ; Lee A; Witek TJ; Kesten S; Towse L
    Chest; 2002 Jul; 122(1):47-55. PubMed ID: 12114338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tiotropium in asthmatic adolescents symptomatic despite inhaled corticosteroids: a randomised dose-ranging study.
    Vogelberg C; Engel M; Moroni-Zentgraf P; Leonaviciute-Klimantaviciene M; Sigmund R; Downie J; Nething K; Vevere V; Vandewalker M
    Respir Med; 2014 Sep; 108(9):1268-76. PubMed ID: 25081651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 4-year trial of tiotropium in chronic obstructive pulmonary disease.
    Tashkin DP; Celli B; Senn S; Burkhart D; Kesten S; Menjoge S; Decramer M;
    N Engl J Med; 2008 Oct; 359(15):1543-54. PubMed ID: 18836213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of aclidinium bromide compared with placebo and tiotropium in patients with moderate-to-severe chronic obstructive pulmonary disease: results from a 6-week, randomized, controlled Phase IIIb study.
    Beier J; Kirsten AM; Mróz R; Segarra R; Chuecos F; Caracta C; Gil EG
    COPD; 2013 Aug; 10(4):511-22. PubMed ID: 23819698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bronchodilator efficacy of 18 μg once-daily tiotropium inhalation via Discair
    Yildiz P; Bayraktaroglu M; Gorgun D; Secik F
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2859-2867. PubMed ID: 27920513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial.
    Tashkin DP; Littner M; Andrews CP; Tomlinson L; Rinehart M; Denis-Mize K
    Respir Med; 2008 Apr; 102(4):479-87. PubMed ID: 18258423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhaled tiotropium for stable chronic obstructive pulmonary disease.
    Barr RG; Bourbeau J; Camargo CA; Ram FS
    Cochrane Database Syst Rev; 2005 Apr; 2005(2):CD002876. PubMed ID: 15846642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with moderate-to-severe COPD (QUANTIFY): a randomised, non-inferiority study.
    Buhl R; Gessner C; Schuermann W; Foerster K; Sieder C; Hiltl S; Korn S
    Thorax; 2015 Apr; 70(4):311-9. PubMed ID: 25677679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium.
    Vogelmeier C; Ramos-Barbon D; Jack D; Piggott S; Owen R; Higgins M; Kramer B;
    Respir Res; 2010 Oct; 11(1):135. PubMed ID: 20920365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tiotropium versus placebo for chronic obstructive pulmonary disease.
    Karner C; Chong J; Poole P
    Cochrane Database Syst Rev; 2012 Jul; (7):CD009285. PubMed ID: 22786525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
    Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
    Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses.
    Tashkin D; Kesten S
    Chest; 2003 May; 123(5):1441-9. PubMed ID: 12740259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of tiotropium and olodaterol on symptoms and patient-reported outcomes in patients with COPD: results from four randomised, double-blind studies.
    Ferguson GT; Karpel J; Bennett N; Clerisme-Beaty E; Grönke L; Voß F; Buhl R
    NPJ Prim Care Respir Med; 2017 Feb; 27(1):7. PubMed ID: 28154373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.